Abstract: Embodiments of the disclosure include an LED lamp driving method and a system in the liquid crystal panel display field. A method of the disclosure includes: adjusting correspondence relations between ports of the LED lamp and channel ports of the LED lamp driving chip first; and then connecting ports of the LED lamp and channel ports of the LED lamp driving chip according to the adjusted the correspondence relations to control light emission of the LED lamp. Aspects of the disclosure include avoiding overheating and even burning of LED lamp driving chips; can be adapted to various LED lamps operation to reduce failure rate of LED lamp operation to the minimum; effectively reduces concentrated heating of the LED lamp driving chip and increases service life of the LED lamp driving chip.

Abstract: A speaker, a television provided with the speaker and a multimedia device are provided. The speaker includes a box body and a plurality of transducer units installed within the box body by means of parallel connection: front sound cavities of the plurality of transducer units are independent of each other, respectively; and the plurality of transducer units share one back sound cavity. The speaker possesses such advantages that it has a high sound pressure level output and a smaller power consumption, it is usable to reduce the back-cavity acoustic resistance, and it is usable to raise the lower frequency limit in the low frequency range.

Abstract: An interactive recognizing system and a display device provided with the interactive recognizing system, which belongs to a technical field of interactive control. The interactive recognizing system comprises: a sensing unit (1) constituted of several sensing devices and configured to receive light signal; a coordinate recognizing unit (2) configured to recognize a coordinate of the light signal received by the sensing unit on the sensing unit and recognize a motion track of the light signal on the sensing unit; a determining unit (3) configured to determine a control instruction represented by the motion track; and an executing unit (4) configured to execute the control instruction.

Abstract: Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents.

Abstract: The embodiments of the present invention provide a display panel driving method, a driving device and a display device, which can improve the time delay of the gate driving signals of a partitioned controlled display panel and reduce the production cost. The display panel comprises at least two time sequence controllers and at least two display areas, each of the time controllers corresponding to one of the display areas respectively; the driving method comprises each of the time sequence controllers obtaining a synchronization signal according to an obtained display signal of the corresponding display area, the synchronization signal comprising a starting time of a first line of scanning signals of the corresponding display area, the time sequence controllers adjusting the starting times of the first lines of the scanning signals according to the synchronization signals of at least one display area so as to make the starting times of the first lines of the scanning signals of all display areas are the same.

Abstract: The co-administration of glufosfamide and a glucose lowering drug other than insulin is efficacious in cancer treatment.

Abstract: Cancer can be treated by administration of a hypoxia-activated prodrug, such as TH-302, alone or in combination with other anticancer agents and/or radiation therapy. In combination therapy, the hypoxia-activated prodrug and another anticancer agent or radiation therapy may be administered within the same 24-hour period, and administration of the hypoxia-activated prodrug may be completed prior to beginning administration of the other anticancer agent or radiation therapy.

Abstract: Cancer can be treated by administration of a hypoxia-activated prodrug, such as TH-302, alone or in combination with other anticancer agents and/or radiation therapy. In combination therapy, the hypoxia-activated prodrug and another anti-cancer agent or radiation therapy may be administered within the same 24-hour period, and administration of the hypoxia-activated prodrug may be completed prior to beginning administration of the other anticancer agent or radiation therapy.

Abstract: The co-administration of glufosfamide and a glucose lowering drug other than insulin is efficacious in cancer treatment.

Abstract: Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents.

Abstract: The present invention provides an array substrate, a driving method and a display device. The array substrate comprises a plurality of gate lines. A first gate line of the two adjacent gate lines is coupled to a first switch unit and a second gate line is coupled to a second switch unit. The first switch unit and the second switch unit are coupled to a control line, and are coupled to a gate drive output channel. The second switch unit is turned off when the first switch unit is turned on under control of the control line, and the first switch unit is turned off when the second switch is turned on under control of the control line. According to the present invention, it is able to effectively reduce the number of the gate drive ICs and thereby to reduce the cost.

Abstract: An array substrate, a liquid crystal display panel and a liquid crystal display device. The array substrate comprises data lines, gate lines and a pixel array provided on a base substrate. Each data line is connected with at least one type of sub-pixels in the pixel array, and sub-pixels of same type connected with a same data line have same polarity, and the sub-pixels connected with the same data line are connected with different gate lines, respectively.

Abstract: Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents.

Abstract: Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents.

Abstract: Various 14-nitro, 14-amino, and 14-substituted amino camptothecin derivatives are useful in the treatment of cancer and other hyperproliferative diseases. 14-Nitro camptothecin derivatives are conveniently prepared by reacting a camptothecin derivative with fuming nitric acid, optionally employing acetic anhydride as a solvent.

Abstract: Compositions containing, and, methods administering, TH302, are useful in treatment of cancer and other hyper-proliferative diseases.

Abstract: Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents.

Abstract: Cancer can be treated by administration of a hypoxia-activated prodrug, such as TH-302, alone or in combination with other anticancer agents and/or radiation therapy. In combination therapy, the hypoxia-activated prodrug and another anti-cancer agent or radiation therapy may be administered within the same 24-hour period, and administration of the hypoxia-activated prodrug may be completed prior to beginning administration of the other anticancer agent or radiation therapy.

Abstract: Hypoxia-activated prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents.

Abstract: Various 14-Nitro, 14-amino, and 14-substituted amino camptothecin derivatives are useful in the treatment of cancer and other hyperproliferative diseases. Various 14-nitro camptothecin derivatives are conveniently prepared by reacting a camptothecin derivative with fuming nitric acid, optionally employing acetic anhydride as a solvent.